Genprex, Inc. (GNPX) News
Track canonical SquawkNews coverage tagged to GNPX, Genprex, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Genprex Collaborates with Roche Diagnostics
Genprex partners with Roche Diagnostics for biomarker studies
EQUITY | Aug 03, 2026, 11:00 AM UTC
M
GNPX: Receives Patent Notice
Genprex receives notice of allowance from CIPO for patent covering use of Reqorsa gene therapy in combination with either PD-1 or PD-L1 antibodies for treatment of lung cancer
EQUITY | Jun 22, 2026, 01:10 PM UTC
H
GNPX Receives Patent Notice
Genprex receives a notice of allowance from the Canadian Intellectual Property Office for a patent claiming the combination of Reqorsa gene therapy with either PD-1 or PD-L1 antibodies to treat cancer
EQUITY | Jun 22, 2026, 01:03 PM UTC